- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
S&P 500 (NYSE:SPY) component Merck & Co (NYSE:MRK) will unveil its latest earnings tomorrow, Friday, February 1, 2013. Merck is a global research-driven company that develops and manufactures a range of innovative pharmaceutical products to improve human and animal health.
Merck & Co Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average analyst estimate is for profit of 81 cents per share, a decline of 16.5% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from 82 cents. Between one and three months ago, the average estimate was unchanged. It has since dropped over the last month. Analysts are projecting profit to rise by 1.1% compared to last year’s $3.81.
Past Earnings Performance: Last quarter, the company beat estimates by 2 cents, coming in at net income of 95 cents a share versus the estimate of profit of 93 cents a share. It marked the fourth straight quarter of beating estimates.
Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!
Wall St. Revenue Expectations: Analysts are projecting a decline of 6.7% in revenue from the year-earlier quarter to $11.47 billion.
A Look Back: In the third quarter, profit rose 2.2% to $1.73 billion (56 cents a share) from $1.69 billion (55 cents a share) the year earlier, exceeding analyst expectations. Revenue fell 4.4% to $11.49 billion from $12.02 billion.
Here’s how Merck & Co traded following its last earnings report 3 months ago and leading up to its upcoming earnings report this week:
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.